Skip to content
Shuttingdown

Avadel Specialty Pharmaceuticals, LLC

Healthcare

Liquidation

High confidence (93%)

Updated Oct 20, 2026, 12:04 AM

What is happening

Derived by rule set status-rules-2026.09.7

The bankruptcy is proceeding as a liquidation.

Latest material event: bankruptcy case closed (docket entry 495) (Oct 26, 2021)

Bankruptcy information

Court records associated with this company's legal entities.

19-10248
Court
D. Delaware
District
Delaware
Chapter
Other
Case status
UNKNOWN
Filed
Feb 6, 2019
Judge
Christopher S. Sontchi
Trustee
—
Reported assets
—
Reported liabilities
—

Timeline

Every material event, newest first. History is never overwritten.

  1. bankruptcy case closed (docket entry 495)

    Oct 26, 2021

    Bankruptcy case closed

    FINAL DECREE AND ORDER CLOSING CHAPTER 11 CASE

    • Epiq — claims agent docket · case 19-10248, entry 495 — “FINAL DECREE”
  2. chapter 11 liquidation (docket entry 429)

    Oct 21, 2020

    Chapter 11 liquidation

    Notice of Effective Date Notice of (A) Occurrence of Effective Date of the First Amended Chapter 11 Plan of Liquidation and (B) Deadlines for Fiing Certain Claims

    • Epiq — claims agent docket · case 19-10248, entry 429 — “Notice of Effective Date”
  3. Creditors of Avadel Specialty Pharmaceuticals, LLC reached the deadline to file claims

    Jul 2, 2019

    Claims deadline

    Avadel Specialty Pharmaceuticals, LLC: General Bar Date. Published by Epiq, the claims and noticing agent appointed in the case.

    • Epiq — claims agent case · case 19-10248 — “Avadel Specialty Pharmaceuticals, LLC — case 19-10248 — Delaware — before Christopher S. Sontchi — filed Feb 06 2019 — 2 affiliated debtors”
  4. AUTHORIZING THE SALE OF ASSETS OF THE DEBTOR FREE AND CLEAR OF ALL LIENS…

    Apr 15, 2019

    Asset sale approved

    ORDER (I) AUTHORIZING THE SALE OF ASSETS OF THE DEBTOR FREE AND CLEAR OF ALL LIENS, CLAIMS, ENCUMBRANCES AND INTERESTS; (II) APPROVING THE FINAL ASSET PURCHASE AGREEMENT; (III) AUTHORIZING THE ASSUMPTION AND ASSIGNMENT OF CERTAIN EXECUTORY CONTRACTS AND UNEXPIRED LEASES; AND (IV) GRANTING RELATED RELIEF

    • Epiq — claims agent docket · case 19-10248, entry 144 — “ORDER (I) AUTHORIZING THE SALE OF ASSETS OF THE DEBTOR FREE AND CLEAR OF ALL LIENS, CLAIMS, ENCUMBRANCES AND INTERESTS; (II) APPROVING THE FINAL ASSET PURCHASE AGREEMENT; (III) AUTHORIZING THE ASSUMPTION AND ASSIGNMENT OF CERTAIN EXECUTORY CONTRACTS AND UNEXPIRED LEASES; AND (IV) GRANTING RELATED RELIEF (Related document(s) [ 143]) Signed on 4/15/2019. (Attachments: # (1) Exhibit A) (DRG)”
  5. Avadel Specialty Pharmaceuticals, LLC had its first day hearing

    Feb 8, 2019

    First day hearing

    Avadel Specialty Pharmaceuticals, LLC: First Day Hearing. Published by Epiq, the claims and noticing agent appointed in the case.

    • Epiq — claims agent case · case 19-10248 — “Avadel Specialty Pharmaceuticals, LLC — case 19-10248 — Delaware — before Christopher S. Sontchi — filed Feb 06 2019 — 2 affiliated debtors”
  6. Avadel Specialty Pharmaceuticals, LLC filed for bankruptcy

    Feb 6, 2019

    Bankruptcy filed

    Avadel Specialty Pharmaceuticals, LLC filed for bankruptcy in D. Delaware as case 19-10248 on Feb 06 2019.

    • Epiq — claims agent case · case 19-10248 — “Avadel Specialty Pharmaceuticals, LLC — case 19-10248 — Delaware — before Christopher S. Sontchi — filed Feb 06 2019 — 2 affiliated debtors”

Company information

Founded
—
Employees (estimate)
—
Industry
Healthcare
Subindustry
—
Website
—
LinkedIn
—
Headquarters
—
Also known as
—
Legal entities
Avadel Specialty Pharmaceuticals, LLC

Sources

Every material source used to build this profile.

  • Epiq Bankruptcy Case Administration (TIER 1 · UNVERIFIED)

    ORDER (I) AUTHORIZING THE SALE OF ASSETS OF THE DEBTOR FREE AND CLEAR OF ALL LIENS, CLAIMS, ENCUMBRANCES AND INTERESTS; (II) APPROVING THE FINAL ASSET PURCHASE AGREEMENT; (III) AUTHORIZING THE ASSUMPTION AND ASSIGNMENT OF CERTAIN EXECUTORY CONTRACTS AND UNEXPIRED LEASES; AND (IV) GRANTING RELATED RELIEF (Related document(s) [ 143]) Signed on 4/15/2019. (Attachments: # (1) Exhibit A) (DRG)
  • Epiq Bankruptcy Case Administration (TIER 1 · UNVERIFIED)

    Avadel Specialty Pharmaceuticals, LLC — case 19-10248 — Delaware — before Christopher S. Sontchi — filed Feb 06 2019 — 2 affiliated debtors
    View source record

Status history

Every derived status, with the rule that produced it.

  • LIQUIDATION → LIQUIDATIONCHAPTER_7_LIQUIDATION · Sep 18, 2026, 01:29 AM

    The bankruptcy is proceeding as a liquidation.

  • LIQUIDATION → LIQUIDATIONCHAPTER_7_LIQUIDATION · Sep 18, 2026, 01:12 AM

    The bankruptcy is proceeding as a liquidation.

  • BANKRUPTCY → LIQUIDATIONCHAPTER_7_LIQUIDATION · Sep 15, 2026, 12:23 PM

    The bankruptcy is proceeding as a liquidation.

  • BANKRUPTCY → BANKRUPTCYCHAPTER_11_BANKRUPTCY · Sep 14, 2026, 04:46 PM

    A bankruptcy case is open. A filing is a legal proceeding, not a confirmation that the company is closed.

  • BANKRUPTCY → BANKRUPTCYCHAPTER_11_BANKRUPTCY · Sep 11, 2026, 12:02 AM

    A bankruptcy case is open. A filing is a legal proceeding, not a confirmation that the company is closed.

  • UNKNOWN → BANKRUPTCYCHAPTER_11_BANKRUPTCY · Sep 9, 2026, 09:28 PM

    A bankruptcy case is open. A filing is a legal proceeding, not a confirmation that the company is closed.